IBDEI1MN ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27603,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,27603,1,3,0)
 ;;=3^Prob Focused
 ;;^UTILITY(U,$J,358.3,27604,0)
 ;;=99202^^107^1370^2
 ;;^UTILITY(U,$J,358.3,27604,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27604,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,27604,1,3,0)
 ;;=3^Expanded Prob Focus
 ;;^UTILITY(U,$J,358.3,27605,0)
 ;;=99203^^107^1370^3
 ;;^UTILITY(U,$J,358.3,27605,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27605,1,2,0)
 ;;=2^99203
 ;;^UTILITY(U,$J,358.3,27605,1,3,0)
 ;;=3^Detailed
 ;;^UTILITY(U,$J,358.3,27606,0)
 ;;=99204^^107^1370^4
 ;;^UTILITY(U,$J,358.3,27606,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27606,1,2,0)
 ;;=2^99204
 ;;^UTILITY(U,$J,358.3,27606,1,3,0)
 ;;=3^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,27607,0)
 ;;=99205^^107^1370^5
 ;;^UTILITY(U,$J,358.3,27607,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27607,1,2,0)
 ;;=2^99205
 ;;^UTILITY(U,$J,358.3,27607,1,3,0)
 ;;=3^Comprehensive, High Complx
 ;;^UTILITY(U,$J,358.3,27608,0)
 ;;=92532^^108^1371^19
 ;;^UTILITY(U,$J,358.3,27608,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27608,1,2,0)
 ;;=2^92532
 ;;^UTILITY(U,$J,358.3,27608,1,3,0)
 ;;=3^Positional Nystagmus Study
 ;;^UTILITY(U,$J,358.3,27609,0)
 ;;=95857^^108^1371^25
 ;;^UTILITY(U,$J,358.3,27609,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27609,1,2,0)
 ;;=2^95857
 ;;^UTILITY(U,$J,358.3,27609,1,3,0)
 ;;=3^Tensilon Test
 ;;^UTILITY(U,$J,358.3,27610,0)
 ;;=64612^^108^1371^4^^^^1
 ;;^UTILITY(U,$J,358.3,27610,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27610,1,2,0)
 ;;=2^64612
 ;;^UTILITY(U,$J,358.3,27610,1,3,0)
 ;;=3^Chemodenervation Face Muscle,Unilateral
 ;;^UTILITY(U,$J,358.3,27611,0)
 ;;=J0585^^108^1371^8^^^^1
 ;;^UTILITY(U,$J,358.3,27611,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27611,1,2,0)
 ;;=2^J0585
 ;;^UTILITY(U,$J,358.3,27611,1,3,0)
 ;;=3^Chemodenervation Supply per unit
 ;;^UTILITY(U,$J,358.3,27612,0)
 ;;=20552^^108^1371^27^^^^1
 ;;^UTILITY(U,$J,358.3,27612,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27612,1,2,0)
 ;;=2^20552
 ;;^UTILITY(U,$J,358.3,27612,1,3,0)
 ;;=3^Trigger Point, 1 or 2 muscles
 ;;^UTILITY(U,$J,358.3,27613,0)
 ;;=20553^^108^1371^28^^^^1
 ;;^UTILITY(U,$J,358.3,27613,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27613,1,2,0)
 ;;=2^20553
 ;;^UTILITY(U,$J,358.3,27613,1,3,0)
 ;;=3^Trigger Point, 3 or more muscles
 ;;^UTILITY(U,$J,358.3,27614,0)
 ;;=20612^^108^1371^14^^^^1
 ;;^UTILITY(U,$J,358.3,27614,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27614,1,2,0)
 ;;=2^20612
 ;;^UTILITY(U,$J,358.3,27614,1,3,0)
 ;;=3^Ganglion Cyst Aspriation/Injection
 ;;^UTILITY(U,$J,358.3,27615,0)
 ;;=64550^^108^1371^24^^^^1
 ;;^UTILITY(U,$J,358.3,27615,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27615,1,2,0)
 ;;=2^64550
 ;;^UTILITY(U,$J,358.3,27615,1,3,0)
 ;;=3^TENS Device Training and Issue
 ;;^UTILITY(U,$J,358.3,27616,0)
 ;;=64450^^108^1371^16^^^^1
 ;;^UTILITY(U,$J,358.3,27616,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27616,1,2,0)
 ;;=2^64450
 ;;^UTILITY(U,$J,358.3,27616,1,3,0)
 ;;=3^Nerve Block, peripheral nerve
 ;;^UTILITY(U,$J,358.3,27617,0)
 ;;=95990^^108^1371^21^^^^1
 ;;^UTILITY(U,$J,358.3,27617,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27617,1,2,0)
 ;;=2^95990
 ;;^UTILITY(U,$J,358.3,27617,1,3,0)
 ;;=3^Refill Spinal Implant Pump by RN
 ;;^UTILITY(U,$J,358.3,27618,0)
 ;;=96402^^108^1371^15^^^^1
 ;;^UTILITY(U,$J,358.3,27618,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27618,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,27618,1,3,0)
 ;;=3^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,27619,0)
 ;;=96372^^108^1371^26^^^^1
